FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1906305575> ?p ?o ?g. }

• W1906305575 endingPage "765" @default.
• W1906305575 startingPage "757" @default.
• W1906305575 abstract "Imatinib is a tyrosine kinase inhibitor that has revolutionized the treatment of chronic myeloid leukemia (CML). Despite its efficacy, about a third of patients discontinue the treatment due to therapy failure or intolerance. The rational identification of patients less likely to respond to imatinib would be of paramount clinical relevance. We have shown that transmembrane transporter hOCT1 genotyping predicts imatinib activity. In parallel, Polycomb group genes (PcGs) are epigenetic repressors implicated in CML progression and in therapy resistance.We measured the expression of eight PcGs in paired pre- and post-imatinib bone marrow samples from 30 CML patients.BMI1, PHC3, CBX6 and CBX7 expression was significantly increased during imatinib treatment. Post-treatment levels of CBX6 and CBX7 predicted 3-month response rate. Measurement of post-treatment BMI1 levels improved the predictive power of hOCT1 genotyping.These results suggest that the expression levels of PcGs might be useful for a more accurate risk stratification of CML patients." @default.
• W1906305575 created "2016-06-24" @default.
• W1906305575 creator A5001285087 @default.
• W1906305575 creator A5003661727 @default.
• W1906305575 creator A5006108984 @default.
• W1906305575 creator A5008586570 @default.
• W1906305575 creator A5013189226 @default.
• W1906305575 creator A5027383577 @default.
• W1906305575 creator A5028804225 @default.
• W1906305575 creator A5029614391 @default.
• W1906305575 creator A5029919899 @default.
• W1906305575 creator A5032349610 @default.
• W1906305575 creator A5037889066 @default.
• W1906305575 creator A5072006834 @default.
• W1906305575 creator A5077344066 @default.
• W1906305575 creator A5079926315 @default.
• W1906305575 creator A5083693387 @default.
• W1906305575 creator A5090381547 @default.
• W1906305575 creator A5091495615 @default.
• W1906305575 date "2015-08-01" @default.
• W1906305575 modified "2023-10-18" @default.
• W1906305575 title "Polycomb genes are associated with response to imatinib in chronic myeloid leukemia" @default.
• W1906305575 cites W1586127326 @default.
• W1906305575 cites W1897003648 @default.
• W1906305575 cites W1971921635 @default.
• W1906305575 cites W1977918192 @default.
• W1906305575 cites W2015735402 @default.
• W1906305575 cites W2016809033 @default.
• W1906305575 cites W2017625776 @default.
• W1906305575 cites W2028959752 @default.
• W1906305575 cites W2029562445 @default.
• W1906305575 cites W2051410505 @default.
• W1906305575 cites W2055980828 @default.
• W1906305575 cites W2059035292 @default.
• W1906305575 cites W2068044096 @default.
• W1906305575 cites W2069481471 @default.
• W1906305575 cites W2103253228 @default.
• W1906305575 cites W2107268345 @default.
• W1906305575 cites W2108251338 @default.
• W1906305575 cites W2110411949 @default.
• W1906305575 cites W2114762637 @default.
• W1906305575 cites W2142188454 @default.
• W1906305575 cites W2152575748 @default.
• W1906305575 cites W2155177044 @default.
• W1906305575 cites W2161841622 @default.
• W1906305575 cites W2162193348 @default.
• W1906305575 cites W2166712471 @default.
• W1906305575 cites W4247760861 @default.
• W1906305575 doi "https://doi.org/10.2217/epi.15.35" @default.
• W1906305575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5551942" @default.
• W1906305575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26343356" @default.
• W1906305575 hasPublicationYear "2015" @default.
• W1906305575 type Work @default.
• W1906305575 sameAs 1906305575 @default.
• W1906305575 citedByCount "17" @default.
• W1906305575 countsByYear W19063055752015 @default.
• W1906305575 countsByYear W19063055752016 @default.
• W1906305575 countsByYear W19063055752017 @default.
• W1906305575 countsByYear W19063055752018 @default.
• W1906305575 countsByYear W19063055752019 @default.
• W1906305575 countsByYear W19063055752020 @default.
• W1906305575 countsByYear W19063055752022 @default.
• W1906305575 countsByYear W19063055752023 @default.
• W1906305575 crossrefType "journal-article" @default.
• W1906305575 hasAuthorship W1906305575A5001285087 @default.
• W1906305575 hasAuthorship W1906305575A5003661727 @default.
• W1906305575 hasAuthorship W1906305575A5006108984 @default.
• W1906305575 hasAuthorship W1906305575A5008586570 @default.
• W1906305575 hasAuthorship W1906305575A5013189226 @default.
• W1906305575 hasAuthorship W1906305575A5027383577 @default.
• W1906305575 hasAuthorship W1906305575A5028804225 @default.
• W1906305575 hasAuthorship W1906305575A5029614391 @default.
• W1906305575 hasAuthorship W1906305575A5029919899 @default.
• W1906305575 hasAuthorship W1906305575A5032349610 @default.
• W1906305575 hasAuthorship W1906305575A5037889066 @default.
• W1906305575 hasAuthorship W1906305575A5072006834 @default.
• W1906305575 hasAuthorship W1906305575A5077344066 @default.
• W1906305575 hasAuthorship W1906305575A5079926315 @default.
• W1906305575 hasAuthorship W1906305575A5083693387 @default.
• W1906305575 hasAuthorship W1906305575A5090381547 @default.
• W1906305575 hasAuthorship W1906305575A5091495615 @default.
• W1906305575 hasBestOaLocation W19063055752 @default.
• W1906305575 hasConcept C104317684 @default.
• W1906305575 hasConcept C121608353 @default.
• W1906305575 hasConcept C126322002 @default.
• W1906305575 hasConcept C135763542 @default.
• W1906305575 hasConcept C143998085 @default.
• W1906305575 hasConcept C203014093 @default.
• W1906305575 hasConcept C2777583451 @default.
• W1906305575 hasConcept C2778729363 @default.
• W1906305575 hasConcept C2778820342 @default.
• W1906305575 hasConcept C2778987575 @default.
• W1906305575 hasConcept C31467283 @default.
• W1906305575 hasConcept C502942594 @default.
• W1906305575 hasConcept C54355233 @default.
• W1906305575 hasConcept C71924100 @default.
• W1906305575 hasConcept C86803240 @default.
• W1906305575 hasConceptScore W1906305575C104317684 @default.

• next